Beijing Hongtianli Pharmaceutical Co., Ltd

Beijing Hongtianli Corporation is a new burgeoning pharmaceutical corporation with advances of capacities for research and development (R&D) of new traditional Chinese medicines. The corporation has obtained three national authorized research achievements, i.e. Qinggan Jiangya Capsule, Yuanhe Tablet and Huwei Tablet, since the foundation of 1999. These achievements are all the products of pure herbal medicine and the corporation has the independent property rights to them. Among them, Qinggan Jiangya Capsule was approved as designated medicine for basic national medical insurance in 2005. The capsule has obvious curative effect on hypertension by tonifying the liver and kidney and dilatating peripheral vascular and distal vessel. The national appraisal results show that the product has comparatively advances to the same kind of new Chinese traditional medicines. Yuanhe Tablet has the action of blood sugar regulating and it may be prescribed for people with hyperglycemia, its total regulating rate is 70% (control experiments on chemical medicines just show a rate of 30%). Huwei Tablet may be prescribed for people with liver injury, it has obvious effects on ALT&AST reducing and putrescencerestrain of hepatic cells.

Another two medicines are being developed: a kind of herbal antibiotic and renal failure. Drug action and toxicology tests show that the antibiotic has obvious effects on restraining and exterminating various bugs and pathogenic bacteria of SARS, A-type flu as well as Candida albicans, pneumococcus, streptococcus, hemophilia influenza and so on. It is also very effective on inflammation and hyperpyrexia caused by viruses and bugs. The medicine for renal failure could repair atrophied or necrotic glomerules or make them regenerate. Both of the two new medicines are non-poisonous drugs and have no side effects and could be taken safely. Another 7 kinds of new traditional Chinese medicines for AID S, blood cancer and hepatitis B will be developed in succession in the 5 coming years. The corporation would like to cooperate with any copartner at various aspects to contribute to hu8man’s health jointly.

Contact: Jia Xiuyi

Tel: 010-83519286, 13701123559